BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
7/14/2025 12:55:58 PM | Browse: 26 | Download: 54
 |
Received |
|
2025-03-24 07:07 |
|
Peer-Review Started |
|
2025-03-24 07:07 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2025-04-03 08:51 |
|
Revised |
|
2025-04-17 07:31 |
|
Second Decision |
|
2025-05-30 02:43 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2025-05-30 06:57 |
|
Articles in Press |
|
2025-05-30 06:57 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2025-06-08 00:45 |
|
Typeset the Manuscript |
|
2025-07-01 00:17 |
|
Publish the Manuscript Online |
|
2025-07-14 12:55 |
| ISSN |
1948-5204 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Oncology |
| Manuscript Type |
Minireviews |
| Article Title |
Targeting SHP2: Dual breakthroughs in colorectal cancer therapy–from signaling pathway modulation to immune microenvironment remodeling
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Pan Liu and Jia Chen |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Zhejiang Provincial Natural Science Foundation for Youths |
QN25H160012 |
| Zhejiang Medical and Health Science and Technology Plan |
2023RC006 |
|
| Corresponding Author |
Jia Chen, Clinical Assistant Professor (Honorary), Pulmonary and Critical Care Medicine, Zhuji Central Hospital, Zhugong Road No.98, Zhuji 311800, Zhejiang Province, China. 13357530129@163.com |
| Key Words |
Colorectal cancer; Protein tyrosine phosphatase SHP2; Targeted therapy; PI3K/AKT pathway; Tumor microenvironment |
| Core Tip |
This paper summarizes the regulatory mechanisms of SHP2 in colorectal cancer (CRC) and emerging therapeutic strategies targeting SHP2. The findings demonstrated that SHP2 serves as a master oncogenic regulator in CRC pathogenesis by coordinating receptor tyrosine phosphatase-mediated signaling. Notably, SHP2 remodels the tumor immune microenvironment by modulating macrophage and T cell functions. Allosteric inhibitors of SHP2, which are characterized by high oral bioavailability and potent target specificity, are currently under evaluation in multicenter phase I/II trials. Although acquired resistance remains challenging, combination strategies, particularly immunotherapy-based treatments, demonstrated transformative potential, accelerating the transition of SHP2-targeted therapies and offering novel paradigms for personalized CRC treatment. |
| Publish Date |
2025-07-14 12:55 |
| Citation |
<p>Liu P, Chen J. Targeting SHP2: Dual breakthroughs in colorectal cancer therapy–from signaling pathway modulation to immune microenvironment remodeling. <i>World J Gastrointest Oncol</i> 2025; 17(7): 107380</p> |
| URL |
https://www.wjgnet.com/1948-5204/full/v17/i7/107380.htm |
| DOI |
https://dx.doi.org/10.4251/wjgo.v17.i7.107380 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
